Heterodinuclear Pt(IV)-Ru(II) anticancer prodrugs to combat both drug resistance and tumor metastasis

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

35 Scopus Citations
View graph of relations


Related Research Unit(s)


Original languageEnglish
Pages (from-to)10735-10738
Journal / PublicationChemical Communications
Issue number71
Online published2 Aug 2016
Publication statusPublished - 14 Sep 2016


A novel approach to design bimetallic anticancer drug candidates with the capability to combat both drug resistance and tumor metastasis is reported. These water-soluble bifunctional Pt(iv)-Ru(ii) heterodinuclear complexes with a unique mode of action display up to 2-orders of magnitude enhanced cytotoxicity in cisplatin-resistant cells and significantly impede cancer cell migration.